These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 19915963)

  • 21. Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial.
    Iglesias JF; Muller O; Heg D; Roffi M; Kurz DJ; Moarof I; Weilenmann D; Kaiser C; Tapponnier M; Stortecky S; Losdat S; Eeckhout E; Valgimigli M; Odutayo A; Zwahlen M; Jüni P; Windecker S; Pilgrim T
    Lancet; 2019 Oct; 394(10205):1243-1253. PubMed ID: 31488372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and Biological Evaluation of Inkjet Printed Drug Coatings on Intravascular Stent.
    Scoutaris N; Chai F; Maurel B; Sobocinski J; Zhao M; Moffat JG; Craig DQ; Martel B; Blanchemain N; Douroumis D
    Mol Pharm; 2016 Jan; 13(1):125-33. PubMed ID: 26592866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-polymer drug-eluting coronary stents.
    Kommineni N; Saka R; Khan W; Domb AJ
    Drug Deliv Transl Res; 2018 Aug; 8(4):903-917. PubMed ID: 28799125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of solvent on drug release and a spray-coated matrix of a sirolimus-eluting stent coated with poly(lactic-co-glycolic acid).
    Choi J; Jang BN; Park BJ; Joung YK; Han DK
    Langmuir; 2014 Aug; 30(33):10098-106. PubMed ID: 25090045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of electrostatic charging on pharmaceutical powder blending homogeneity.
    Pu Y; Mazumder M; Cooney C
    J Pharm Sci; 2009 Jul; 98(7):2412-21. PubMed ID: 18855912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymer-Free Drug-Eluting Stents: An Overview of Coating Strategies and Comparison with Polymer-Coated Drug-Eluting Stents.
    Chen W; Habraken TC; Hennink WE; Kok RJ
    Bioconjug Chem; 2015 Jul; 26(7):1277-88. PubMed ID: 26041505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro and in vivo evaluation of a novel polymer-free everolimus-eluting stent by nitrogen-doped titanium dioxide film deposition.
    Park DS; Bae IH; Jeong MH; Lim KS; Sim DS; Hong YJ; Lee SY; Jang EJ; Shim JW; Park JK; Lim HC; Kim HB
    Mater Sci Eng C Mater Biol Appl; 2018 Oct; 91():615-623. PubMed ID: 30033294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial.
    Kandzari DE; Mauri L; Koolen JJ; Massaro JM; Doros G; Garcia-Garcia HM; Bennett J; Roguin A; Gharib EG; Cutlip DE; Waksman R;
    Lancet; 2017 Oct; 390(10105):1843-1852. PubMed ID: 28851504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Meta-Analysis of Randomized Clinical Trials Comparing Biodegradable Polymer Drug-Eluting Stent to Second-Generation Durable Polymer Drug-Eluting Stents.
    El-Hayek G; Bangalore S; Casso Dominguez A; Devireddy C; Jaber W; Kumar G; Mavromatis K; Tamis-Holland J; Samady H
    JACC Cardiovasc Interv; 2017 Mar; 10(5):462-473. PubMed ID: 28279314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative spatial distribution of sirolimus and polymers in drug-eluting stents using confocal Raman microscopy.
    Balss KM; Llanos G; Papandreou G; Maryanoff CA
    J Biomed Mater Res A; 2008 Apr; 85(1):258-70. PubMed ID: 17876804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymer-based or Polymer-free Stents in Patients at High Bleeding Risk.
    Windecker S; Latib A; Kedhi E; Kirtane AJ; Kandzari DE; Mehran R; Price MJ; Abizaid A; Simon DI; Worthley SG; Zaman A; Hudec M; Poliacikova P; Abdul Ghapar AKB; Selvaraj K; Petrov I; Mylotte D; Pinar E; Moreno R; Fabbiocchi F; Pasupati S; Kim HS; Aminian A; Tie C; Wlodarczak A; Hur SH; Marx SO; Jankovic I; Brar S; Bousquette L; Liu M; Stone GW;
    N Engl J Med; 2020 Mar; 382(13):1208-1218. PubMed ID: 32050061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Explaining electrostatic charging and flow of surface-modified acetaminophen powders as a function of relative humidity through surface energetics.
    Jallo LJ; Dave RN
    J Pharm Sci; 2015 Jul; 104(7):2225-32. PubMed ID: 25974039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of stent strut endothelialization in iliac arteries of rabbits.
    Takimura CK; Watanabe IS; Laurindo FR; Gutierrez PS; Aiello VD; Morato SP; Lemos Neto PA
    Arq Bras Cardiol; 2012 Dec; 99(6):1123-8. PubMed ID: 23152288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of a novel nano-porous polymer-free sirolimus-eluting stent in pigs.
    Chen M; Zheng B; Wu Z; Peng HY; Wang XG; Zhang B; Huo Y
    Chin Med J (Engl); 2013; 126(24):4731-5. PubMed ID: 24342320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sustained clinical safety and efficacy of a biodegradable-polymer coated sirolimus-eluting stent in "real-world" practice: three-year outcomes of the CREATE (Multi-Center Registry of EXCEL Biodegradable Polymer Drug Eluting Stents) study.
    Han Y; Jing Q; Li Y; Yang L; Liu H; Shang X; Jiang T; Li Z; Zhang H; Yan G;
    Catheter Cardiovasc Interv; 2012 Feb; 79(2):211-6. PubMed ID: 21523893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized optical coherence tomography study of coronary stent strut coverage and luminal protrusion with rapamycin-eluting stents.
    Moore P; Barlis P; Spiro J; Ghimire G; Roughton M; Di Mario C; Wallis W; Ilsley C; Mitchell A; Mason M; Kharbanda R; Vincent P; Sherwin S; Dalby M
    JACC Cardiovasc Interv; 2009 May; 2(5):437-44. PubMed ID: 19463468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel polymer-free paclitaxel-eluting stent with a nanoporous surface for rapid endothelialization and inhibition of intimal hyperplasia: Comparison with a polymer-based sirolimus-eluting stent and bare metal stent in a porcine model.
    Jia H; Liu H; Kong J; Hou J; Wu J; Zhang M; Tian J; Liu H; Ma L; Hu S; Huang X; Zhang S; Zhang S; Yu B; Jang IK
    J Biomed Mater Res A; 2011 Sep; 98(4):629-37. PubMed ID: 21732525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Solventless pharmaceutical coating processes: a review.
    Bose S; Bogner RH
    Pharm Dev Technol; 2007; 12(2):115-31. PubMed ID: 17510883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Electrostatic powder coating: Principles and pharmaceutical applications.
    Prasad LK; McGinity JW; Williams RO
    Int J Pharm; 2016 May; 505(1-2):289-302. PubMed ID: 27085644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 1-Year Clinical Outcomes of All Comers Treated With 2 Bioresorbable Polymer-Coated Sirolimus-Eluting Stents: Propensity Score-Matched Comparison of the COMBO and Ultrathin-Strut Orsiro Stents.
    Chandrasekhar J; Kok MM; Kalkman DN; Aquino MB; Zocca P; Woudstra P; Beijk MA; Kerkmeijer LS; Sartori S; Baber U; Tijssen JG; Koch KT; Dangas GD; Colombo A; Pocock S; von Birgelen C; Mehran R; de Winter RJ;
    JACC Cardiovasc Interv; 2020 Apr; 13(7):820-830. PubMed ID: 32273094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.